DD297814A5 - Glycerolderivat und seine pharmakologische anwendung - Google Patents

Glycerolderivat und seine pharmakologische anwendung Download PDF

Info

Publication number
DD297814A5
DD297814A5 DD89330340A DD33034089A DD297814A5 DD 297814 A5 DD297814 A5 DD 297814A5 DD 89330340 A DD89330340 A DD 89330340A DD 33034089 A DD33034089 A DD 33034089A DD 297814 A5 DD297814 A5 DD 297814A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
group
solvent
glycerol derivative
pharmacologically acceptable
Prior art date
Application number
DD89330340A
Other languages
German (de)
English (en)
Inventor
Kazuo Okano
Osamu Asano
Naoyuki Shimomura
Tetsuya Kawahara
Shinya Abe
Shuhei Miyazawa
Mitsuaki Miyamoto
Hiroyuki Yoshimura
Koukichi Harada
Junsaku Nagaoka
Tsutomu Kawata
Tsutomu Yoshimura
Hiromasa Suzuki
Shigeru Souda
Yoshimasa Machida
Kouichi Katayama
Isao Yamatsu
Original Assignee
�����@�K�K�Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �����@�K�K�Kk�� filed Critical �����@�K�K�Kk��
Publication of DD297814A5 publication Critical patent/DD297814A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD89330340A 1988-07-04 1989-07-03 Glycerolderivat und seine pharmakologische anwendung DD297814A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16638688 1988-07-04

Publications (1)

Publication Number Publication Date
DD297814A5 true DD297814A5 (de) 1992-01-23

Family

ID=15830457

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89330340A DD297814A5 (de) 1988-07-04 1989-07-03 Glycerolderivat und seine pharmakologische anwendung

Country Status (20)

Country Link
US (1) US5037827A (zh)
EP (1) EP0353474B1 (zh)
JP (1) JP2766319B2 (zh)
KR (1) KR910006127B1 (zh)
CN (1) CN1041920C (zh)
AT (1) ATE120734T1 (zh)
AU (1) AU621634B2 (zh)
CA (1) CA1334753C (zh)
DD (1) DD297814A5 (zh)
DE (1) DE68922035T2 (zh)
DK (1) DK329189A (zh)
ES (1) ES2070148T3 (zh)
FI (1) FI97883C (zh)
GR (1) GR3015704T3 (zh)
HU (2) HUT62855A (zh)
NO (1) NO177495C (zh)
NZ (1) NZ229789A (zh)
PH (1) PH26045A (zh)
PT (1) PT91051B (zh)
RU (1) RU2040521C1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662606A1 (fr) * 1990-06-01 1991-12-06 Rhone Poulenc Sante Compositions pharmaceutiques pour le traitement de la fibrillation ventriculaire, du syndrome de menace de l'infarctus du myocarde et de l'angine de poitrine contenant le n-(benzoyl-3 phenyl) (pyridyl-3)-3 1h,3h-pyrrolo[1,2-c]thiazolecarboxamide-7.
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5700817A (en) * 1992-06-30 1997-12-23 Pohang Iron & Steel Co., Ltd. Cyclic lipid derivatives as potent PAF antagonists
ES2130274T3 (es) * 1992-06-30 1999-07-01 Po Hang Iron & Steel Nuevos derivados lipidicos ciclicos como potentes antagonistas del factor activador de las plaquetas (paf).
JPH07285866A (ja) * 1994-02-22 1995-10-31 Eisai Co Ltd 臓器障害予防・治療・改善剤
US5854279A (en) * 1996-06-04 1998-12-29 Eisai Co., Ltd Therapeutic agent for dermatosis
US6177067B1 (en) 1996-08-09 2001-01-23 Shiseido Company, Ltd. Hair revitalizing tonic composition containing a 2,2-dimethylpropanediol compound and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014778B1 (de) * 1979-02-19 1983-05-18 BBC Aktiengesellschaft Brown, Boveri & Cie. Zweistüfiges Abgasturboladeraggregat
ZA8410014B (en) * 1983-12-30 1985-08-28 Hoffmann La Roche Glycerol derivatives
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
US4737518A (en) * 1984-04-03 1988-04-12 Takeda Chemical Industries, Ltd. Lipid derivatives, their production and use
DE3586746D1 (de) * 1984-04-03 1992-11-19 Takeda Chemical Industries Ltd Lipidderivate, ihre produktion und verwendung.
US4863941A (en) * 1985-06-18 1989-09-05 Hoffmann-La Roche Inc. Glycerol derivatives
JPH0815643B2 (ja) * 1988-05-19 1996-02-21 新日本製鐵株式会社 幅可変薄スラブ連続鋳造機の湯面レベル制御方法

Also Published As

Publication number Publication date
PT91051B (pt) 1995-06-30
NO892743D0 (no) 1989-07-03
KR910006127B1 (ko) 1991-08-13
EP0353474A2 (en) 1990-02-07
DK329189A (da) 1990-01-05
US5037827A (en) 1991-08-06
HU208119B (en) 1993-08-30
CN1041920C (zh) 1999-02-03
PT91051A (pt) 1990-02-08
EP0353474B1 (en) 1995-04-05
KR900001654A (ko) 1990-02-27
FI893099A (fi) 1990-01-05
NO177495B (no) 1995-06-19
NO892743L (no) 1990-01-05
AU621634B2 (en) 1992-03-19
RU2040521C1 (ru) 1995-07-25
JPH02131467A (ja) 1990-05-21
ES2070148T3 (es) 1995-06-01
DK329189D0 (da) 1989-07-03
CN1039414A (zh) 1990-02-07
HU9202211D0 (en) 1992-12-28
FI97883B (fi) 1996-11-29
JP2766319B2 (ja) 1998-06-18
NO177495C (no) 1995-09-27
HUT52478A (en) 1990-07-28
ATE120734T1 (de) 1995-04-15
CA1334753C (en) 1995-03-14
PH26045A (en) 1992-01-29
DE68922035D1 (de) 1995-05-11
NZ229789A (en) 1991-04-26
GR3015704T3 (en) 1995-07-31
HUT62855A (en) 1993-06-28
FI97883C (fi) 1997-03-10
AU3721389A (en) 1990-01-04
EP0353474A3 (en) 1991-03-27
FI893099A0 (fi) 1989-06-26
DE68922035T2 (de) 1995-09-14

Similar Documents

Publication Publication Date Title
EP0004920B1 (de) Carbazolyl-(4)-oxy-propanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69032020T2 (de) N-Substituierte 4-Pyrimidinamine und -Pyrimidindiamine, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE68923387T2 (de) 2',3'-Dideoxy-2',2'-difluornucleoside.
DE2341753C2 (de) α-(3-tert.Butylamino-α-hydroxy-propylthio)- Thiazolderivate, Verfahren zu deren Herstellung und dieselben enthaltende pharmazeutische Zubereitung
EP0528762B1 (de) N-Acyl-N-Heterocyclyl- oder Naphthylalkyl-Aminosäuren als Angiotensin II Antagonisten
EP0005848A1 (de) N-Alkylierte Aminoalkohole und ihre Salze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0656353B1 (de) Aminochinolin-Derivate mit einer Wirksamkeit gegen Malariaerreger
DE2520910A1 (de) Cyclisch substituierte derivate des 1-amino-2-propanol
DE2738477C2 (zh)
DE3044740A1 (de) Nucleosidderivate, ihre herstellung und pharmazeutische mittel
DE60011916T2 (de) Heteroaryloxypropanolamine als beta3-adrenergischer rezeptor-agonisten
DD297814A5 (de) Glycerolderivat und seine pharmakologische anwendung
DE69401177T2 (de) 1-Aryloxy-3-alkylamino-2 propanol nitrat Ester, ihre Anwendung und korrespondierende pharmazeutische Zusammensetzungen
DD287496A5 (de) Verfahren zur herstellung von 4-phenyl-3-butensaeurederivaten
EP0208932A2 (de) Glycerinderivate
DE2065312C3 (de) Aminoäthansulfonylderivate und Verfahren zu ihrer Herstellung
DE3027106C2 (zh)
EP0271099A2 (de) Substituierte Aminopropionsäureamide, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung sowie die bei der Herstellung anfallenden neuen Zwischenprodukte
DE602004002692T2 (de) Verfahren zur Herstellung von Topiramate
CH638784A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
DE2740678A1 (de) 1-amino-2-hydroxy-3-heterocycloxypropane
DE69018268T2 (de) Verfahren zur herstellung von geschützten aza-yperiten prodrugs.
EP0663395B1 (de) 3-(Phenylalkylaminoalkyloxy)-5-phenylpyrazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als herzfrequenzsenkendes Mittel
EP0135162A2 (de) Weinsäuremonoester von optisch aktiven Alkanolaminen, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19830167B4 (de) Neue Azatyrosin-Analoga

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20090704